Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2651-2660 of 2762 for

Edit search filters
  1. Genetic Risk Estimation and Improving Health Disparities in Breast Cancer Screening of Racial Minorities

    Jacksonville, FL

  2. A Study to Evaluate Quality of Life Over Time in Patients Treated with CAR-T Cell Therapy Compared with Stem Cell Transplantation in Hematologic Malignancies

    Rochester, MN

  3. Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study of Leukemia Inhibitory Factor Biomarker Monitoring Progression and Treatment Response of Locally-advanced Unresectable and Metastatic Pancreatic Cancer Therapies

    Jacksonville, FL

  5. Analyzing Oesophago-Gastric Leaks From Diagnosis to Management

    Jacksonville, FL

  6. International Precision Medicine Consortium for Neurooncology Research

    Rochester, MN

  7. OPX Saliva Biomarker Study

    Rochester, MN

  8. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls

    Rochester, MN

  9. Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy in Prostate Carcinoma

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  10. A Registry for Children Treated with Proton Radiation Therapy

    Rochester, MN

.

Mayo Clinic Footer